My petitions
Membership
Search
Start a petition
Log in
Topic

Hsv-1

  • 4,326 supporters taking action on this topic.
  • 1 petition started in this community.
Start a petition

Explore 1 petition in Hsv-1

Support accelerated development of ABI-1179 for HSV treatment

United States

150 signatures

Topics related to Hsv-1

Public HealthTechnologyHealthcare ReformHealth and Well-beingGovernment and PoliticsDrug and Medicine RegulationHerpesHerpes Vaccine

Stories and updates from petition starters

Accelerate development of IM-250 (Adibelivir) HSV Functional Cure -Preventing Transmission
Let’s get more signatures for this petition! We are so close to 3,500! 🏆😁Hi all, I wanted to let you know that we now have 3440 signatures on this petition. Thank you so much for your support! Would you…Read full update
March 5, 2026
Accelerate development of IM-250 (Adibelivir) HSV Functional Cure -Preventing Transmission
Please Share this PetitionWe are reaching great Milestones as a community ♥️🙏🏽 Give yourselves a round of applause. Thank you. There is still more to do…Read full update
February 24, 2026
Accelerate development of IM-250 (Adibelivir) HSV Functional Cure -Preventing Transmission
🌸🎊 WE MADE IT TO 3k Signatures 🎉🥳Thank you, We have a reached a great milestone. Most petition do not make this far but WE, Did. You owe yourself a round of appl…Read full update
February 11, 2026

You’re not alone — a community of supporters is ready to back you.

Start a petition
  1. Home
  2. Topic
  3. Hsv-1
  4. Home
  5. Topic
  6. Hsv-1

Get involved

Start a petitionBrowse by topicBrowse by locationFor NonprofitsSearch for petitions

Learn

Petition guidesCreate your petitionCollect signaturesReach out to mediaEngage your Decision Maker

About us

AboutImpactTeamCareersPress

Help & legal

Help centerCommunity guidelinesPrivacy policyTerms of serviceCookie policyManage cookies

Follow us

InstagramXFacebookTikTokBlog


© 2026, Change.org, PBCThis site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.